Hookipa Pharma Inc Reports Results For The Quarter Ended In December: Earnings Summary

Hookipa Pharma

15/03/2023 13:31

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in December. The
mean expectation of seven analysts for the quarter was for a
loss of 21 cents per share.
    * Revenue rose 101% to $7.83 million from a year ago;
analysts
expected $7.07 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * HOOKIPA Pharma Inc shares had held steady so far this
quarter.
    * The company reported a quarterly loss of $12.31 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 01:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.21          -0.17          Beat
 Sep. 30 2022      -0.28          -0.25          Beat
 Jun. 30 2022      -0.36          -0.23          Beat
 Mar. 31 2022      -0.24          -0.40          Missed